canakinumab   Click here for help

GtoPdb Ligand ID: 6773

Synonyms: ACZ 885 | ACZ885 | Ilaris®
Approved drug Immunopharmacology Ligand
canakinumab is an approved drug (FDA (2009), EMA (2009))
Compound class: Antibody
Comment: Canakinumab targets interleukin-1β [1].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2009), EMA (2009))
International Nonproprietary Names Click here for help
INN number INN
8836 canakinumab
Synonyms Click here for help
ACZ 885 | ACZ885 | Ilaris®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 244
Other databases
GtoPdb PubChem SID 178103379
PubChem SID 178103379
Search PubMed clinical trials canakinumab
Search PubMed titles canakinumab
Search PubMed titles/abstracts canakinumab
SynPHARM 78932 (in complex with interleukin 1 beta)
Wikipedia Canakinumab